FreeCME

Selecting the Right Insulin and the Right Regimen for the Right Patient

Jointly provided by Postgraduate Institute for Medicine and Horizon CME.

This activity is supported by education grants from Lilly USA, LLC and Sanofi US Diabetes.

Scroll to the Bottom of this Information to Begin This Course

Release date: August 20, 2014

Valid through: December 17, 2015

Estimated Time to Complete Activity: 1 hour (per module)

Specialty: Primary Care Physicians

Target Audience

This activity has been designed to meet the educational needs of primary care physicians, nurse practitioners, physician assistants and registered nurses involved in the management of patients with Type II Diabetes.

 

How Does Insulin Initiation & Adjustment Effect My Patients? In-Depth Patient Case with Medication Simulator

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Apply strategies to individualize antihyperglycemic therapy in patients with type 2 diabetes to personalize A1C goals
  • Incorporate appropriate management strategies for timely initiation, selection, titration, and self-management of insulin in patients with type 2 diabetes
  • Discuss the advantages and disadvantages of basal-plus, basal-bolus, and pre-mixed insulin regimens for the treatment of patients with type 2 diabetes
  • Implement strategies for overcoming the barriers to insulin initiation, persistence and adherence
  • Discuss how emerging basal insulins address current unmet needs for improved PK and PD profiles

Start Module

 

Hot Topic Q & A in Insulin Initiation & Management

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Apply strategies to individualize antihyperglycemic therapy in patients with type 2 diabetes to personalize A1C goals
  • Incorporate appropriate management strategies for timely initiation, selection, titration, and self-management of insulin in patients with type 2 diabetes
  • Discuss the advantages and disadvantages of basal-plus, basal-bolus, and pre-mixed insulin regimens for the treatment of patients with type 2 diabetes
  • Implement strategies for overcoming the barriers to insulin initiation, persistence and adherence
  • Discuss how emerging basal insulins address current unmet needs for improved PK and PD profiles

Start Module

 

Managing Insulin in Diabetes Patients: Medical Simulator based Patient Care

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Apply strategies to individualize antihyperglycemic therapy in patients with type 2 diabetes to personalize A1C goals
  • Incorporate appropriate management strategies for timely initiation, selection, titration, and self-management of insulin in patients with type 2 diabetes
  • Discuss the advantages and disadvantages of basal-plus, basal-bolus, and pre-mixed insulin regimens for the treatment of patients with type 2 diabetes

Start Module

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ (for each module)

All other healthcare professionals completing this course will be issued a statement of participation.

Faculty

Christopher Newton, MD
Atlanta Diabetes Associates
Atlanta, GA

Robert Tanenberg, MD, FACP
Professor of Medicine, Division of Endocrinology Medical Director,
Diabetes and Obesity Institute, East Carolina University
Medical Director, Inpatient Diabetes Program, Vidant Medical Center
Greenville, NC

Dawn Smiley-Byrd, MD
Associate Professor of Medicine, Emory University School of Medicine
Atlanta, GA

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Horizon CME. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Christopher Newton, MD
  • Hereby states that he or his spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME activity of any amount during the past 12 months.
Robert Tanenberg, MD, FACP
  • Consulting Fees (e.g., advisory boards): Sanofi US
  • Contracted Research: Sanofi US
Dawn Smiley-Byrd, MD
  • Consulting Fees (e.g., advisory boards): Boehringer Ingelheim, Sanofi US, Janssen
  • Contracted Research: Merck, Sanofi US, Abbott Nutrition

The planners and managers at Horizon CME, Brian Lee, PharmD and Elizabeth Wilkerson, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. Cara Williams, PharmD reported that her husband has served on an advisory board for Sanofi U.S.

The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, MSN, RN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The planners and managers at Horizon CME, Brian Lee, PharmD and Elizabeth Wilkerson, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. Cara Williams, PharmD reported that her husband has served on an advisory board for Sanofi U.S.

Instructions for Participation and Credit

There are no fees for participating and receiving credit for this activity. During the period August 2014 through December 17, 2015, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) complete the post-test and the evaluation form; and 4) Claim credit within the activity.

To answer the questions, click on your selected choice for each answer then proceed to the next question.

If you successfully complete the post-test (score of 65% or higher), your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you receive a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.

Media

Internet

Hardware and Software Requirements

Supported Browsers:

  • Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
  • Google Chrome 28.0+ for Windows, Mac OS, or Linux
  • Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
  • Safari 5.0+ for Mac OSX 10.5 and above

Supported Phones & Tablets:

  • Android 4.0.3 and above
  • iPhone/iPad with iOS 6.1 or above

For video playback, install the latest version of Flash or Quicktime. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser.

Disclosure Of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Modules